Bill
HB 2529
An Act amending the act of April 14, 1972 (P.L.233, No.64), known as The Controlled Substance, Drug, Device and Cosmetic Act, further providing for schedules of controlled substances and for secure storage of xylazine; and adding provisions relating to medetomidine.
2025-2026 Regular Session
Introduced by Johanny Cepeda-Freytiz and 7 co-sponsors
HB 2529 would place medetomidine in Schedule III and tighten secure storage rules for xylazine to curb misuse and strengthen regulated-substance controls.
Third consideration and final passage